SERUM IMMUNOGLOBULIN AND COMPLEMENT LEVELS IN PATIENTS WITH BREAST CANCER IN IRAQ
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i6.25060Keywords:
Breast cancer, Iraqi women, Complements, ImmunoglobulinsAbstract
Objective: The objective of this study was to estimate the serum immunoglobulins (IgA, IgM, and IgG) levels, and complements (C3 and C4) level in Iraqi women with breast cancer pre-treatment and post-treatment.
Methods: A total number of 100 patients aged 25–47 years were enrolled in this study, including 35 breast cancer treatment patients, 30 treatment patients, and 10 and 25 healthy women benefactor. All samples were collected from August 2016 to February 2017 from Oncology Hospital/Medical city in Baghdad exception of the control group were collected from outside the hospital. Serum levels of IgG, IgA, IgM, C3, and C4 were measured by radial immunodiffusion technique.
Results: Serum mean values of IgA, IgG, and C3were significantly higher (p˂0.01) in patients pre-treatment than in post-treatment. The level of the serum for patients pre-treatment was significantly higher than post-treatment.
Conclusion: The present study showed the increase of serum IgA, IgG, and C3 levels can be considered as biomarker for breast cancer diagnosis pre-treatment and post-treatment.
Downloads
References
Globocan 2012. International Agency for Research on Cancer. Lyon: IARC Press; 2013.
Adama AB, Mohamed S. Anti–Breast cancer from various natural sources, review. Int J Pharm Pharm Sci 2015;7:44-7.
Iraqi Cancer Board. Results of the Iraqi Cancer Registry 2012. Baghdad: Iraqi Cancer Registry Center, Ministry of Health; 2015.
Alwan NA. Breast cancer among Iraqi women: Preliminary findings from a regional comparative breast cancer research project. J Glob Oncol ASCO 2016;2:1-4.
Al Alwan NA. Proliferative index as a marker in Iraqi aneuploid mammary carcinoma. WHO, East. Mediterr Health J 2000;6:1062-72.
Ahluwalia S, Shah N. Animal venom for treating breast cancer. Int J Pharm PharmSci 2015;6:24-30.
Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 1999;13:1382 97.
Yadav R, Sen R, Chauhanp ER. PR, HER2/Neu status and relation to clinicopathological factors in breast Carcinoma. Int J Pharm PharmSci 2017;8:287-90.
Singh B, Berry JA, Shoher A, Lucci A. COX-2 induces IL-11 production in human breast cancer cells. J Surg Res 2006;131:267-75.
Singh RP, Singh VP, Udupa KN. E-rosette forming lymphocytes and serum immunoglobulins in breast cancer patients. Mater Med Pol (Polish Journal Of Medicine And Pharmacy) 1991;23:179-81.
Vijayakumar T, Ankathil R, Remani P, Beevi VM, Vijayan KK, Panicker CK, et al. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breast. J Clin Immunol 1987;7:300-3.
Benjamin E, Leskowitz S. Immunology: A Short Course. 2nd ed. New York: John Wiley and Sons Inc.; 1991.
Goldsby RA, Kindt TJ, Osborene BA. Kuby Immunology. 4th ed. New York, U.S.A: W.H. Free Man and Company; 2000.
Shreiber H. Tumor immunology. In: Panl WE. Fundamental Immunology. 4th ed. Philadelphia, PA: Lippincott. Raven Publisher; 1999. p. 1237-70.
Mancini G, Carbonara AO, Heremans JF. Immuno-chemical quantitation of antigens by single radial immunodiffusion. Immunochemistry
;2:235-4.
Springer GF, Desai PR, Scanlon EF. Blood group MN precursors as human breast carcinoma-associated antigens and naturally†occurring human cytotoxins against them. Cancer 1976;37:169-76.
Alsabti EA. Serum immunoglobulins in breast cancer. J Surg Oncol 2006;11:129-33.
Zheng H, Li M, Ren W, Zeng L, Liu HD, Hu D, et al. Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Mol Immunol 2007;44:2221-7.
Ali HQ, Mahdi NK, Al-jowher MH. Serum igand cytokinelevels in women with breast cancer before and aftermastectomy. Med J Islam World Acad Sci 2012;20:121-9.
Chen Z, Qiu X, Gu J. Immunoglobulin expression in nonlymphoid lineage and neoplastic cells. Am J Pathol 2009;174:1139-48.
Niculescu F, Rus HG, Retegan M, Vlaicu R. Persistent complement activation on tumor cells in breast cancer. Am J Pathol 1992;140:1039 43.
Ferda O, İsmail S, Numan N. Immunoglobulins and complement components in patients with lung cancer. Tüberkülozve Toraks Dergisi 2004;52:19-23.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
